Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NEFH pseudogene 2 (NEFHP2) is a member of the pseudogene family located on human chromosome 20 (hg38: chr20:41997131-41999397)[1]. Pseudogenes are defective copies of functional genes, often arising by duplication or retrotransposition, that no longer encode a functional protein or produce a detectable gene product[7][8]. NEFHP2 is homologous to the **neurofilament heavy polypeptide gene (NEFH)**, which is a structural protein in neurons, but NEFHP2 itself is non-functional and has no verified protein-coding capacity, signaling property, or known biological role in disease modulation[6][7][8]. Therefore, it is not a therapeutic target and should not be confused with the functional NEFH gene. This entry represents a **non-functional pseudogene** and does **not** meet criteria for drug targeting, biomarker use, or therapeutic intervention[6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEFH pseudogene 2 (NEFHP2).